AVANOS MEDICAL (AVNS) Competitors $12.02 +0.06 (+0.50%) As of 10:27 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVNS vs. AORT, EYE, ENOV, CNMD, NVCR, SSII, ESTA, CDRE, BLFS, and PLSEShould you be buying AVANOS MEDICAL stock or one of its competitors? The main competitors of AVANOS MEDICAL include Artivion (AORT), National Vision (EYE), Enovis (ENOV), CONMED (CNMD), NovoCure (NVCR), SS Innovations International (SSII), Establishment Labs (ESTA), Cadre (CDRE), BioLife Solutions (BLFS), and Pulse Biosciences (PLSE). These companies are all part of the "medical equipment" industry. AVANOS MEDICAL vs. Its Competitors Artivion National Vision Enovis CONMED NovoCure SS Innovations International Establishment Labs Cadre BioLife Solutions Pulse Biosciences AVANOS MEDICAL (NYSE:AVNS) and Artivion (NYSE:AORT) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership. Which has preferable earnings & valuation, AVNS or AORT? Artivion has lower revenue, but higher earnings than AVANOS MEDICAL. Artivion is trading at a lower price-to-earnings ratio than AVANOS MEDICAL, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAVANOS MEDICAL$687.80M0.81-$392.10M-$10.07-1.19Artivion$388.54M5.31-$13.36M-$0.42-104.20 Does the media favor AVNS or AORT? In the previous week, AVANOS MEDICAL and AVANOS MEDICAL both had 10 articles in the media. AVANOS MEDICAL's average media sentiment score of 1.23 beat Artivion's score of 0.84 indicating that AVANOS MEDICAL is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AVANOS MEDICAL 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Artivion 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders have more ownership in AVNS or AORT? 95.2% of AVANOS MEDICAL shares are owned by institutional investors. Comparatively, 86.4% of Artivion shares are owned by institutional investors. 2.6% of AVANOS MEDICAL shares are owned by insiders. Comparatively, 8.1% of Artivion shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts prefer AVNS or AORT? Artivion has a consensus price target of $40.63, indicating a potential downside of 7.16%. Given Artivion's stronger consensus rating and higher possible upside, analysts clearly believe Artivion is more favorable than AVANOS MEDICAL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AVANOS MEDICAL 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Artivion 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more volatility and risk, AVNS or AORT? AVANOS MEDICAL has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Comparatively, Artivion has a beta of 1.7, meaning that its share price is 70% more volatile than the S&P 500. Is AVNS or AORT more profitable? Artivion has a net margin of -4.43% compared to AVANOS MEDICAL's net margin of -66.89%. AVANOS MEDICAL's return on equity of 6.16% beat Artivion's return on equity.Company Net Margins Return on Equity Return on Assets AVANOS MEDICAL-66.89% 6.16% 4.57% Artivion -4.43%5.70%2.29% SummaryArtivion beats AVANOS MEDICAL on 10 of the 16 factors compared between the two stocks. Get AVANOS MEDICAL News Delivered to You Automatically Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVNS vs. The Competition Export to ExcelMetricAVANOS MEDICALMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$558.05M$7.08B$5.77B$21.38BDividend YieldN/A1.19%6.66%3.49%P/E Ratio-1.1925.3883.0529.02Price / Sales0.8155.78527.2348.80Price / Cash1.0122.4425.7018.29Price / Book0.726.9611.005.30Net Income-$392.10M$174.83M$3.28B$997.87M7 Day Performance1.14%-0.12%-0.19%-0.47%1 Month Performance9.39%3.72%8.33%6.49%1 Year Performance-49.99%8.72%53.31%13.66% AVANOS MEDICAL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVNSAVANOS MEDICAL2.6082 of 5 stars$12.02+0.5%N/A-50.6%$559.40M$687.80M-1.202,227Positive NewsAORTArtivion3.3075 of 5 stars$43.53-2.9%$40.63-6.7%+60.9%$2.12B$388.54M-103.641,600EYENational Vision3.6044 of 5 stars$23.93-3.6%$24.73+3.3%+107.8%$1.97B$1.82B-132.9413,411Positive NewsENOVEnovis4.3714 of 5 stars$30.98-1.5%$51.00+64.6%-33.7%$1.80B$2.11B-2.177,367Positive NewsCNMDCONMED4.6103 of 5 stars$54.35-2.6%$59.80+10.0%-27.0%$1.73B$1.33B15.403,900Positive NewsNVCRNovoCure3.989 of 5 stars$11.70-5.9%$28.79+146.0%-37.3%$1.39B$605.22M-7.501,488News CoverageSSIISS Innovations InternationalN/A$6.98-0.1%N/AN/A$1.35B$20.65M0.004ESTAEstablishment Labs2.0876 of 5 stars$40.66-6.8%$56.50+39.0%-12.0%$1.26B$166.02M-13.331,018News CoveragePositive NewsCDRECadre3.3987 of 5 stars$30.27-2.5%$31.50+4.0%-14.8%$1.26B$567.56M32.212,284Positive NewsBLFSBioLife Solutions1.7777 of 5 stars$25.65-1.0%$31.29+22.0%-2.1%$1.24B$82.25M-213.73440PLSEPulse Biosciences4.0184 of 5 stars$16.49-3.3%$22.00+33.4%-18.9%$1.15B$700K-15.70140News CoveragePositive News Related Companies and Tools Related Companies Artivion Competitors National Vision Competitors Enovis Competitors CONMED Competitors NovoCure Competitors SS Innovations International Competitors Establishment Labs Competitors Cadre Competitors BioLife Solutions Competitors Pulse Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AVNS) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVANOS MEDICAL, INC. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVANOS MEDICAL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVNS Stock Alerts